MAS — Masco Corporation

The tape, not the analyst community, is setting the tone as of 2026-09-13: MAS sits 5.05% below its 20-day SMA, 8.82% below its 50-day and 1.80% below its 200-day, with RSI(14) at 37.07 and one-week/one-month returns of -5.75%/-8.2%. The Q2 2026 report (July 29) missed revenue ($1.99B vs ~$2.08B consensus) and the $1.64 EPS beat vs $1.32 was driven largely by one-time IEEPA tariff refunds, so the market is discounting the quality of the beat even as management raised FY26 guidance to $4.40–$4.60. Wells Fargo cut its target to $82 from $87, DA Davidson initiated Neutral at $80 citing limited upside, and Zacks trimmed Q3 2026 EPS to $0.99 — a constructive-but-cautious analyst stance (20 Buy / 16 Hold / 2 Sell, $82.40 consensus target) that price action has overridden for now.

Revenue is flat-to-slightly-declining, not accelerating: YoY changes of -1.9% (Q2'25), -6.5% (Q1'25), -3.3% (Q3'25), -1.9% (Q4'25), +6.5% (Q1'26) and -2.9% (Q2'26), with quarterly revenue oscillating in a narrow $1.79B–$2.09B band since late 2023. Margins are stable, not inflecting: TTM operating margin was 17.7% at 2026-06-30 vs 17.6% a year earlier, but the quarterly path is noisy — Q2'26 operating margin spiked to 23.6% (gross margin 43.6% vs 37.7% in Q2'25) on the tariff refund, while Q4'25/Q1'26 dipped to 14.4%/16.5%. EPS is the cleanest growth line ($1.60 diluted in Q2'26 vs $1.28 a year ago, +25%), but a meaningful slice of that is the refund and the rest is a shrinking share count (~199M diluted vs ~211M a year earlier). Verdict: a mature, structurally flat top line with mid-single-digit EPS growth engineered through cost control and buybacks — stable rather than inflecting, and the latest quarter is a one-off-boosted blip, not the start of a new growth trend.

Fair-to-modestly-cheap as of 2026-09-13. At $68.55 the stock is 15.8x TTM EPS ($4.45) and ~15.1x the $4.53 next-FY consensus, versus a 5-year average P/E of 21.6x — a ~27% discount — with a 1.09 PEG and 11.1x EV/EBITDA. The discount is real but partly optical: strip roughly $0.35/share of one-time tariff refund from FY26 guidance and clean EPS is nearer $4.15, putting the stock at ~16.5x clean earnings rather than 15x. On sales it is not cheap at all — P/S of 1.77 vs a 5-year average of 1.80 — which tells you the 'cheap vs. its own history' signal comes from margin expansion and buyback-driven EPS, not an underperforming revenue line. Against a justified 17x on ~$4.45 of normalized forward EPS, fair value lands in the mid-$70s, modestly above the current quote.

The market is paying ~16.5x clean forward earnings for a business with zero revenue growth — i.e., it is pricing a housing-turnover recovery it cannot yet see, but only mildly. Do not extrapolate Q2 2026's $1.60 diluted EPS: Q3 2026 consensus has already reset to $0.99, and the raised $4.40–$4.60 FY guide leans on an $85–95M refund that does not repeat. If pro-remodel demand holds and buybacks keep retiring ~4–5% of the share count annually, EPS can grind toward ~$4.50 clean in 2027 and the multiple can re-rate to 17–18x — the ~$76–82 zone. If gross margin reverts from Q2's 43.6% to the ~36–38% underlying trend without a volume recovery, the 'cheap' 15x becomes a fair 16–17x on lower numbers and the stock stays range-bound in the $60s.

Weak, but not yet washed out. As of 2026-09-13, RSI(14) stood at 37.07 — soft but above the ~30 oversold line — with the shares 5.05% under the 20-day SMA, 8.82% under the 50-day and 1.80% under the 200-day, i.e. a short-term downtrend inside a longer-term range. Returns of -5.75% (1wk), -8.2% (1mo) and -7.44% (3mo) have killed momentum, though the 6-month return is still +11.38%. Entry implication: high-30s RSI with price near the bottom of the $58.16–$83.64 range favors starting to scale in, not backing up the truck — there is no reversal confirmation until the stock reclaims its 50-day, and a decisive break below the low-to-mid $60s would signal the market is pricing something worse than a flat housing cycle.

• Elevated mortgage rates and the lock-in effect are suppressing existing-home sales, housing turnover and the discretionary DIY big-ticket spending that historically accompanies a move.
• Offsetting that, aging North American housing stock and a strong home-equity base keep non-discretionary repair, maintenance and professional remodel activity flowing — a demand floor for Delta/Hansgrohe and Behr.
• Tariff and commodity dynamics are the swing factor: mid-single-digit commodity inflation plus shifting trade policy, where the IEEPA refunds produced a one-time $85–95M net FY26 benefit that will not recur and could reverse.
• The Fed's easing path into 2027 is the single biggest cyclical lever — any meaningful drop in mortgage rates would unlock deferred remodel demand and re-rate the whole building-products group.
• Consumer discretionary pressure and mass-market retail sell-through (heavy big-box channel concentration) mean Masco has limited pricing power if volumes stay soft.
• Sector rotation: a 1.29 beta, low-growth housing-exposed name tends to lag in risk-on, rate-cut-driven rotations until the earnings inflection is visible.

• Q3 2026 earnings, expected around October 29, 2026 — the key test of whether pro-remodel demand offsets soft DIY and whether gross margin holds anywhere near Q2's 43.6% without the tariff refund.
• Any acceleration in Fed rate cuts or a visible turn in existing-home sales, which would unlock deferred remodel spend and drive multiple re-rating.
• Continued aggressive capital return — $454M returned in Q2 2026 (dividends plus buybacks) on top of a $300M accelerated share repurchase — supporting ~4–5% annual share-count reduction and a ~6–7% total shareholder yield.
• Trade-policy or tariff rulings that either extend the refund/cost relief or reverse it, moving FY26–FY27 EPS by a few dollars-cents per share.
• New CMO Brad Hiranaga's enterprise growth agenda (appointed late July 2026) and any portfolio/brand actions or bolt-on M&A.
• Balance-sheet repair narrative: negative stockholders' equity (-$365M at 2026-06-30) versus a very comfortable 1.87 current ratio — either direction of travel will be scrutinized.

• A structural, not cyclical, DIY slowdown: revenue has been flat-to-down for six straight quarters ($1.79B–$2.09B range) and could stay there if mortgage lock-in persists into 2027.
• Earnings quality — the Q2 2026 beat and the raised $4.40–$4.60 guide are anchored by a non-repeating $85–95M IEEPA tariff refund; clean EPS power is roughly $4.15, not $4.50.
• Negative stockholders' equity (-$365M at 2026-06-30) combined with $3.245B of long-term debt leaves little book-value cushion; buyback-funded capital return becomes harder to sustain in a downturn.
• Margin normalization risk: TTM operating margin (17.7%) and Q2's 23.6% print are the high-water mark; a return to the ~36–38% gross-margin trend without volume recovery compresses EPS and the multiple simultaneously.
• Channel concentration in big-box home centers and continued commodity/tariff cost inflation that cannot be fully passed through at current demand levels.

Masco is a genuinely high-return, cash-generative business — 26.2% ROIC, ~17.7% operating margin, a -9.35% accruals ratio (net income of ~$885M TTM running well behind ~$1.45B of trailing free cash flow), a 1.87 current ratio and only $3.245B of long-term debt — trading at ~15.1x forward earnings against a 21.6x five-year average, with a 1.7% dividend and roughly 5% annual share shrinkage. The catch is that growth is cyclical-weak, not absent: revenue has been flat for six quarters, and the latest EPS beat is partly a one-time tariff refund, so the near-term case rests on the housing cycle bottoming rather than on the company's own momentum. For a patient 12–24 month holder willing to scale in on weakness, the risk/reward at $68.55 is favorable; this is not a momentum trade, and I would not chase it above the mid-$70s.

Method: warranted forward P/E on normalized EPS. Start from FY2026 guidance of $4.40–$4.60 (midpoint $4.50), strip the non-recurring ~$0.35/share IEEPA tariff-refund benefit to get ~$4.15 of clean 2026 EPS, then grow that ~8% into FY2027 (~4–5% from continued share-count reduction, ~3% from cost/mix) for ~$4.48 of normalized forward EPS; applying a 17x multiple — justified between the current 15.1x forward and the 21.6x five-year average, given 26.2% ROIC and 17.7% operating margins but flat revenue and housing cyclicality — yields $76. Cross-checks: 11.5x on ~$1.5B EV/EBITDA implies ~$71, and a normalized ~$1.0B FCF stream at a 7–7.5% yield implies $65–72, so $76 is the optimistic end of a $70–$76 fair-value band and reflects the buyback compounding plus a housing-cycle recovery that is not yet visible in the numbers.